Prognostic Value of Biomarkers in Polyneuropathy. — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Prognostic Value of Biomarkers in Polyneuropathy. — Stella

Recruiting

Back to Polyneuropathies trials

Trial locations(1 site)

Denmark

Copenhagen Neuromuscular Center, Department of Neurology, Rigshospitalet, Copenhagen

Key details

Sponsor

Rigshospitalet, Denmark

Enrollment target

~200 participants

Started

October 2023

Primary completion

October 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated April 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov